Circulating Non-Coding RNAs in Head and Neck Cancer: Roles in Diagnosis, Prognosis, and Therapy Monitoring.
biomarkers
circulating non-coding RNA
head and neck cancer
liquid biopsy
Journal
Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052
Informations de publication
Date de publication:
31 12 2020
31 12 2020
Historique:
received:
21
11
2020
revised:
27
12
2020
accepted:
28
12
2020
entrez:
5
1
2021
pubmed:
6
1
2021
medline:
29
6
2021
Statut:
epublish
Résumé
Head and neck cancer (HNC), the seventh most common form of cancer worldwide, is a group of epithelial malignancies affecting sites in the upper aerodigestive tract. The 5-year overall survival for patients with HNC has stayed around 40-50% for decades, with mortality being attributable mainly to late diagnosis and recurrence. Recently, non-coding RNAs, including tRNA halves, YRNA fragments, microRNAs (miRNAs), and long non-coding RNAs (lncRNAs), have been identified in the blood and saliva of patients diagnosed with HNC. These observations have recently fueled the study of their potential use in early detection, diagnosis, and risk assessment. The present review focuses on recent insights and the potential impact that circulating non-coding RNA evaluation may have on clinical decision-making in the management of HNC.
Identifiants
pubmed: 33396240
pii: cells10010048
doi: 10.3390/cells10010048
pmc: PMC7823329
pii:
doi:
Substances chimiques
Biomarkers, Tumor
0
RNA, Untranslated
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Références
Int J Cancer. 2007 Oct 15;121(8):1813-20
pubmed: 17546592
Mol Cancer. 2014 Sep 19;13:218
pubmed: 25233933
Nat Cell Biol. 2011 Apr;13(4):423-33
pubmed: 21423178
Laryngoscope. 2019 Aug;129(8):1836-1843
pubmed: 30570748
BMJ. 2002 Oct 12;325(7368):822-7
pubmed: 12376446
Cell Physiol Biochem. 2018;50(4):1429-1440
pubmed: 30355951
Clin Biochem. 2015 Feb;48(3):115-21
pubmed: 25485932
Nat Struct Mol Biol. 2012 Sep;19(9):900-5
pubmed: 22885326
BMC Genomics. 2013 May 02;14:298
pubmed: 23638709
Br J Cancer. 2014 Jan 21;110(2):392-8
pubmed: 24327016
Front Immunol. 2019 Jan 15;9:3164
pubmed: 30697216
Cancer Metastasis Rev. 2017 Sep;36(3):411-423
pubmed: 28801840
J Mol Biol. 2013 Oct 9;425(19):3582-600
pubmed: 23500488
Br J Cancer. 2008 Mar 11;98(5):981-8
pubmed: 18283318
Genes (Basel). 2018 May 10;9(5):
pubmed: 29748504
Front Oncol. 2019 Sep 26;9:959
pubmed: 31616639
Mol Cell Biol. 2006 Sep;26(18):6993-7004
pubmed: 16943439
J Hematol Oncol. 2019 May 24;12(1):51
pubmed: 31126316
BMC Bioinformatics. 2017 Jan 13;18(1):32
pubmed: 28086747
Commun Biol. 2020 Feb 5;3(1):56
pubmed: 32024996
Oncotarget. 2015 Aug 7;6(22):19246-63
pubmed: 26057471
Proc Natl Acad Sci U S A. 2011 Mar 22;108(12):5003-8
pubmed: 21383194
Oncotarget. 2017 Jun 20;8(25):41166-41177
pubmed: 28467811
Biomarkers. 2018 Mar;23(2):137-141
pubmed: 28135849
FEBS Lett. 2012 Apr 24;586(8):1226-30
pubmed: 22575660
Cancer Sci. 2020 May;111(5):1711-1723
pubmed: 32155300
Nature. 2012 Sep 6;489(7414):101-8
pubmed: 22955620
Cancers (Basel). 2019 Mar 15;11(3):
pubmed: 30875950
Tumour Biol. 1996;17(2):81-9
pubmed: 8658017
N Engl J Med. 1998 Aug 27;339(9):591-8
pubmed: 9718378
Cell Physiol Biochem. 2018;47(1):26-38
pubmed: 29763905
Oncotarget. 2017 Jan 31;8(5):8206-8214
pubmed: 28030794
Cancer Biomark. 2017;19(2):193-197
pubmed: 28211800
Med Sci Monit. 2016 Jan 27;22:289-94
pubmed: 26813876
Genome Res. 2012 Sep;22(9):1775-89
pubmed: 22955988
Oncotarget. 2017 May 23;8(21):34534-34551
pubmed: 28427185
Cancer. 1997 Apr 1;79(7):1401-8
pubmed: 9083163
Cancer Epidemiol. 2019 Feb;58:137-145
pubmed: 30579238
Int J Cancer. 1999 Oct 22;84(5):525-8
pubmed: 10502732
Semin Cancer Biol. 2014 Jun;26:99-115
pubmed: 24751797
Clin Chem. 2014 May;60(5):773-82
pubmed: 24563490
Mamm Genome. 2008 Aug;19(7-8):454-92
pubmed: 18839252
Oral Oncol. 2016 Dec;63:30-37
pubmed: 27938997
Head Neck Oncol. 2010 Jun 29;2:15
pubmed: 20587061
N Engl J Med. 2010 Jul 1;363(1):24-35
pubmed: 20530316
Cancers (Basel). 2020 Apr 10;12(4):
pubmed: 32290144
Nat Commun. 2019 Nov 5;10(1):5026
pubmed: 31690716
Cancer. 2008 Aug 15;113(4):750-7
pubmed: 18536030
J Transl Med. 2019 Jun 3;17(1):186
pubmed: 31159814
Nat Cell Biol. 2007 Jun;9(6):654-9
pubmed: 17486113
Cell. 2019 Nov 14;179(5):1033-1055
pubmed: 31730848
Nature. 2005 Jun 9;435(7043):834-8
pubmed: 15944708
Sci Signal. 2009 Dec 08;2(100):ra81
pubmed: 19996457
Cells. 2020 May 21;9(5):
pubmed: 32455790
BMC Cancer. 2019 Aug 28;19(1):843
pubmed: 31455274
J Natl Cancer Inst. 2008 Feb 20;100(4):261-9
pubmed: 18270337
Biomark Med. 2020 Oct;14(14):1393-1404
pubmed: 33073579
FEBS Lett. 2018 Sep;592(17):2884-2900
pubmed: 29972883
Cancer Lett. 2020 Oct 1;489:111-120
pubmed: 32561417
Nucleic Acids Res. 2013 Jan;41(Database issue):D246-51
pubmed: 23042674
PLoS One. 2012;7(10):e46367
pubmed: 23056289
Biomed Res Int. 2018 Jan 18;2018:7329195
pubmed: 29581984
Tumour Biol. 2016 Jan;37(1):447-53
pubmed: 26224475
Adv Exp Med Biol. 2016;937:3-17
pubmed: 27573892
Expert Rev Mol Diagn. 2014 Jul;14(6):699-712
pubmed: 24938122
Viruses. 2019 Oct 09;11(10):
pubmed: 31600915
Int J Cancer. 2014 Mar 15;134(6):1359-68
pubmed: 23999999
Int J Cancer. 2019 May 15;144(10):2555-2566
pubmed: 30411781
Nat Rev Cancer. 2015 Jun;15(6):321-33
pubmed: 25998712
Chin J Cancer. 2014 Jul;33(7):330-8
pubmed: 24874644
Front Genet. 2015 Jan 26;6:2
pubmed: 25674102
Nature. 2016 Mar 24;531(7595):518-22
pubmed: 27008969
Ann Surg Oncol. 2013 Dec;20 Suppl 3:S406-14
pubmed: 23138850
Nature. 2017 Mar 9;543(7644):199-204
pubmed: 28241135
Carcinogenesis. 2017 May 1;38(5):485-491
pubmed: 28449079
Tumour Biol. 2016 Mar;37(3):3969-78
pubmed: 26482616
Nature. 2011 Sep 21;478(7367):57-63
pubmed: 21937992
Int J Cancer. 2018 Dec 15;143(12):3209-3217
pubmed: 29971780
FEBS Lett. 2005 May 23;579(13):2948-52
pubmed: 15893315
Cancer. 1979 Dec;44(6):2120-3
pubmed: 509391
J Med Genet. 2013 Jul;50(7):425-30
pubmed: 23620220
Dis Markers. 2019 Nov 18;2019:8632018
pubmed: 31827646
Nat Cell Biol. 2019 May;21(5):542-551
pubmed: 31048766